Cetuximab + radiotherapy good value for head and neck cancer

By  

Inpharma, Vol. 1, Iss. 1576, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Cost-effectiveness analysis comparing degarelix with leuprolide in hormonal therapy for patients with locally advanced prostate cancer

By Hatoum Hind T   Crawford E David   Nielsen Sandy Kildegaard   Lin Swu-Jane   Marshall Dennis C  

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 13, Iss. 2, 2013-04 ,pp. : 261-270

Informa Healthcare

Access to resources Recommend Favorite

Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: A prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module

By Rosenthal David I.   Mendoza Tito R.   Fuller Clifton D.   Hutcheson Katherine A.   Wang X. Shelley   Hanna Ehab Y.   Lu Charles   Garden Adam S.   Morrison William H.   Cleeland Charles S.   Gunn G. Brandon  

Cancer, Vol. 120, Iss. 13, 2014-07 ,pp. : 1975-1984

Blackwell Publishing

Access to resources Recommend Favorite

Recent Advances in Combined Modality Therapy for Locally Advanced Head and Neck Cancer

By  

Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-11 ,pp. : 674-680

Bentham Science Publishers

Access to resources Recommend Favorite

Adding cetuximab to RT: ahead for cost effectiveness in Taiwan

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 640, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite